Épimède capital is a private fund (PRICAF under Belgian law). It aims to invest in private capital, non-listed, of high-growth technological SMEs. Our strategy focuses on promising companies in early stage phase whose growth potential is demonstrated or in effective growth. Funds raised have to be invested in priority in the financing of growth accelaration.

We give priority to partners we can bring a real added-value in terms of growth support. As such, Épimède will play an active role within the Board of Directors of the target company and will take part in the control of key, strategic decisions.

The amounts raised from Épimède have to be mainly attributed to the subscription of new equity.

Address: Rue Lambert-Lombard 3, 4000 Liège


Philippe Degeer
Marc Foidart
Bernard Surlemont

Telephone: +32 4 221 62 21


Website: http://epimede.com/en/